Cuándo y cómo debemos combinas DES con stents convencionales en América Latina Dr. Eduardo Souza

More articles by this author

Nuevos datos sobre estudios y registros en implante carotídeo Dr. Mathias Klauss

Nuevos datos sobre estudios y registros en implante carotídeo Dr. Mathias Klauss

Actualización del Programa Xience-V/Promus Dr. Gregg Stone

Actualización del Programa Xience-V/Promus Dr. Gregg Stone

Stenting de la arteria renal: Dónde estamos y hacia dónde vamos Dr. Stephen Ramee

Stenting de la arteria renal: Dónde estamos y hacia dónde vamos Dr. Stephen Ramee

PCI después de COURAGE para pacientes con enfermedad coronaria estable Dr. Carlos Macaya

PCI después de COURAGE para pacientes con enfermedad coronaria estable Dr. Carlos Macaya

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Drug-Eluting Stents in Peripheral Arterial Disease: When Should They Be Used?

Peripheral drug-eluting stents have transformed the treatment of peripheral arterial disease by reducing restenosis rates and the need for repeat interventions. However, the emergence...

OCT-Detected High-Risk Plaques Predict Recurrent Events After Myocardial Infarction

After a myocardial infarction (MI), non-culprit lesions are often deferred when they are not flow-limiting (negative FFR). However, these lesions continue to represent an...

Ticagrelor vs Clopidogrel in ACS Patients Receiving DOAC After PCI: More Bleeding Without Ischemic Benefit?

In patients with acute coronary syndrome (ACS) who require direct oral anticoagulation (DOAC) and undergo percutaneous coronary intervention (PCI), current guidelines recommend a dual...